Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Hirsch

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Human Gene Therapy|May 12, 2017
Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?Nolan Brown, Liujiang Song, Nageswara R Kollu, et al.
Journal of Virology|November 8, 2013
Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replicationAngela M Mitchell, Matthew L Hirsch, Chengwen Li, et al.
Human Molecular Genetics|December 23, 2017
Inhibition of antigen presentation during AAV gene therapy using virus peptidesWenwei Shao, Xiaojing Chen, Richard J Samulski, et al.
Plos One|November 6, 2009
AAV recombineering with single strand oligonucleotidesMatthew L Hirsch, Francesca Storici, Chengwen Li, et al.
Journal of Virology|May 6, 2016
Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput ScreensSarah C Nicolson, Chengwen Li, Matthew L Hirsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2017
Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J MiceTelmo Llanga, Nadia Nagy, Laura Conatser, et al.
Molecular Therapy. Oncology|August 13, 2025
Allele-specific depletion of <i>GNAQ</i> <sup>Q209L</sup> via siRNA or an rAAV2-shRNA vector induces selective toxicity in <i>GNAQ</i> <sup>Q209L</sup> uveal melanoma cellsTrace F McCall, Emma J Sawyer, Joshua Darnell, et al.
Gene Therapy|August 4, 2018
Serotype survey of AAV gene delivery via subconjunctival injection in miceLiujiang Song, Telmo Llanga, Laura M Conatser, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequenceMarina Pryadkina, William Lostal, Nathalie Bourg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapyBrian C Gilger, Tomoko Hasegawa, R Bryan Sutton, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Human Gene Therapy|May 12, 2017
Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?Nolan Brown, Liujiang Song, Nageswara R Kollu, et al.
Journal of Virology|November 8, 2013
Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replicationAngela M Mitchell, Matthew L Hirsch, Chengwen Li, et al.
Human Molecular Genetics|December 23, 2017
Inhibition of antigen presentation during AAV gene therapy using virus peptidesWenwei Shao, Xiaojing Chen, Richard J Samulski, et al.
Plos One|November 6, 2009
AAV recombineering with single strand oligonucleotidesMatthew L Hirsch, Francesca Storici, Chengwen Li, et al.
Journal of Virology|May 6, 2016
Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput ScreensSarah C Nicolson, Chengwen Li, Matthew L Hirsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2017
Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J MiceTelmo Llanga, Nadia Nagy, Laura Conatser, et al.
Molecular Therapy. Oncology|August 13, 2025
Allele-specific depletion of <i>GNAQ</i> <sup>Q209L</sup> via siRNA or an rAAV2-shRNA vector induces selective toxicity in <i>GNAQ</i> <sup>Q209L</sup> uveal melanoma cellsTrace F McCall, Emma J Sawyer, Joshua Darnell, et al.
Gene Therapy|August 4, 2018
Serotype survey of AAV gene delivery via subconjunctival injection in miceLiujiang Song, Telmo Llanga, Laura M Conatser, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequenceMarina Pryadkina, William Lostal, Nathalie Bourg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapyBrian C Gilger, Tomoko Hasegawa, R Bryan Sutton, et al.
Pageof 5